Similar articles

• Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.

  Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B. Wahl P, et al. N Engl J Med. 1983 Apr 14;308(15):862-7. doi: 10.1056/NEJM198304143081502. N Engl J Med. 1983. PMID: 6572785
• Complications of oral contraceptive agents--a symposim. Contraceptives and lipid metabolism.

  Fiser RH. Fiser RH. West J Med. 1975 Jan;122(1):35-8. West J Med. 1975. PMID: 162816 Free PMC article. Review. No abstract available.
• [Metabolism of circulating lipids in patients taking oral contraceptives].

  Turpin G, Menage JJ. Turpin G, et al. Sem Hop. 1973 Oct 26;49(43):2833-8. Sem Hop. 1973. PMID: 4362577 Clinical Trial. French. No abstract available.
• Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse.

  Lohe VK, Degwekar SS, Bhowate RR, Kadu RP, Dangore SB. Lohe VK, et al. J Oral Pathol Med. 2010 Feb;39(2):141-8. doi: 10.1111/j.1600-0714.2009.00828.x. Epub 2009 Dec 7. J Oral Pathol Med. 2010. PMID: 20002982
• Oral contraceptives and cardiovascular disease (second of two parts).

  Stadel BV. Stadel BV. N Engl J Med. 1981 Sep 17;305(12):672-7. doi: 10.1056/NEJM198109173051205. N Engl J Med. 1981. PMID: 7022211 Review. No abstract available.